Form 4 for XTNT Xtant Medical Holdings, Inc.
Accepted 2021-07-13 00:00:00 ET · period of report 2021-07-09 · accession 0001235802-21-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-13 | 2021-07-09 | XTNT | Brandt Kevin D | Chief Commercial Off | F - Tax | $1.74 | -8,800 | 161.6K | -5% | -$15.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.000001 par value | 2021-07-09 | F | D | 8,800 | $1.74 | 161,552 | D | — | — | (F1) Includes 121,560 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan. |